Loading...
OTCM
VYCO
Market cap4mUSD
Jul 02, Last price  
0.13USD
1D
-0.08%
Jan 2017
-61.17%
IPO
560.00%
Name

Vycor Medical Inc

Chart & Performance

D1W1MN
P/E
P/S
3.02
EPS
Div Yield, %
Shrs. gr., 5y
8.58%
Rev. gr., 5y
-0.65%
Revenues
1m
+19.43%
2,565129,947199,046316,450971,3671,205,2631,089,3741,250,2921,138,6341,452,7141,384,9711,509,3301,481,7511,142,0451,392,9871,222,9891,460,604
Net income
-70k
L-82.83%
-593,996-2,381,295-1,141,383-1,961,662-4,778,541-2,926,210-2,472,773-4,049,713-2,082,643-1,652,280-1,477,045-1,379,356-864,885-900,296-523,473-405,881-69,691
CFO
29k
P
-429,633-1,171,622-543,786-1,450,270-3,195,334-1,370,930-730,143-2,700,769-1,167,500-496,918-527,438-260,3227,221-248,79121,369-217,01629,430
Earnings
Aug 11, 2025

Profile

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.
IPO date
Mar 31, 2009
Employees
6
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,461
19.43%
1,223
-12.20%
Cost of revenue
168
141
Unusual Expense (Income)
NOPBT
1,293
1,082
NOPBT Margin
88.53%
88.50%
Operating Taxes
6
Tax Rate
0.57%
NOPAT
1,293
1,076
Net income
(70)
-82.83%
(406)
-22.46%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
867
848
Long-term debt
389
176
Deferred revenue
Other long-term liabilities
(146)
Net debt
1,199
986
Cash flow
Cash from operating activities
29
(217)
CAPEX
(9)
(3)
Cash from investing activities
(9)
(3)
Cash from financing activities
211
166
FCF
1,560
1,496
Balance
Cash
57
37
Long term investments
Excess cash
Stockholders' equity
(32,690)
(32,295)
Invested Capital
30,474
30,349
ROIC
4.25%
3.56%
ROCE
EV
Common stock shares outstanding
32,604
31,708
Price
Market cap
EV
EBITDA
1,354
1,144
EV/EBITDA
Interest
103
92
Interest/NOPBT
7.97%
8.52%